What is the recommended management for allergic rhinitis in pediatric patients?

Management of Pediatric Allergic Rhinitis

Intranasal corticosteroids are the most effective first-line therapy for moderate-to-severe allergic rhinitis in children and should be initiated as monotherapy before considering any combination treatments. 1, 2

First-Line Treatment: Intranasal Corticosteroids

• Intranasal corticosteroids control all nasal symptoms—congestion, rhinorrhea, sneezing, and itching—more effectively than oral antihistamines or leukotriene receptor antagonists. 1, 2
• These agents are superior to oral antihistamines specifically for nasal congestion, which depends on type 2 inflammation and vasodilation. 3
• Monotherapy with intranasal corticosteroid is strongly recommended over combination therapy with oral antihistamine for initial treatment. 2
• Critical technique: Direct the nasal spray away from the nasal septum toward the lateral nasal wall to prevent mucosal erosions and potential septal perforations. 1
• Maximum dose should not exceed 200 mcg/day of fluticasone nasal spray, as higher doses provide no additional benefit. 2

Second-Line Treatment: Add Intranasal Antihistamine

• If intranasal corticosteroid monotherapy fails to control moderate-to-severe symptoms after adequate trial, add an intranasal antihistamine (not an oral antihistamine). 1
• The combination of intranasal antihistamine plus intranasal corticosteroid provides greater symptom reduction than either agent alone. 1
• Do NOT add oral antihistamines to intranasal corticosteroids—multiple high-quality trials demonstrate no additional benefit. 1
• Do NOT add leukotriene receptor antagonists (montelukast) to intranasal corticosteroids, as they provide no additional benefit. 1

Alternative Monotherapy for Mild Symptoms

• For children with mild intermittent allergic rhinitis who do not require intranasal corticosteroids, second-generation oral antihistamines are appropriate. 4
• Cetirizine dosing: 10 mg once daily for ages 6 years and older; 5 mg once daily for ages 2-5 years. 2
• Second-generation antihistamines (cetirizine, loratadine) cause minimal sedation (0.4-3% at recommended doses) compared to first-generation agents. 2
• Avoid first-generation antihistamines due to sedation and cognitive impairment in children. 2

Adjunctive Therapies

• Nasal saline irrigation is safe, inexpensive, and effective for removing secretions, allergens, and mediators; hypertonic solutions provide additional decongestant activity. 1, 3
• Intranasal ipratropium bromide (0.03%) effectively reduces rhinorrhea but has no effect on other symptoms; it can be combined with intranasal corticosteroids for additive benefit. 1

Third-Line Treatment: Allergen Immunotherapy

• Refer patients with inadequate response to optimal pharmacologic therapy for allergen-specific immunotherapy (subcutaneous or sublingual), which is the only disease-modifying treatment that can alter the natural history of allergic rhinitis. 1
• Immunotherapy may prevent development of new allergen sensitizations and reduce future asthma risk. 1

Critical Pitfalls to Avoid

• Never use intranasal decongestants for more than 3-10 days—prolonged use causes rhinitis medicamentosa (rebound congestion). 1
• Never prescribe oral corticosteroids for routine management of allergic rhinitis; reserve them only for severe, intractable cases. 2
• Do not use oral decongestants (pseudoephedrine, phenylephrine) in patients with cardiac arrhythmia, angina, cerebrovascular disease, hypertension, bladder neck obstruction, glaucoma, or hyperthyroidism. 1

Assessment of Comorbid Conditions

• Always evaluate for associated conditions: asthma, atopic dermatitis, sleep-disordered breathing, conjunctivitis, rhinosinusitis, and otitis media. 1
• Treatment of allergic rhinitis with intranasal corticosteroids may improve asthma control in patients with coexisting asthma. 1
• Consider surgical referral for severe nasal septal deviation, inferior turbinate hypertrophy, adenoidal hypertrophy, or refractory sinusitis. 1

Environmental Control

• Implement allergen avoidance strategies for identified triggers early, even during initial pharmacologic treatment. 1

Reassessment Strategy

• If a patient with moderate-to-severe persistent allergic rhinitis fails to improve after 4 weeks of adequate treatment, reassess patient compliance and reconsider the diagnosis. 5
• When diagnosis is uncertain, perform careful clinical examination including nasal endoscopy to assess for other potential causes of nasal obstruction. 5

Pediatric-Specific Considerations

• Almost all studies informing these recommendations included exclusively adult patients, but relative treatment effects are likely similar in children, though adverse effects and their perception may differ (e.g., bitter taste). 4
• Values and preferences for specific outcomes and treatments can vary between adults and children. 4
• The fixed combination of topical antihistamine plus topical corticosteroid in a single spray is very effective but indicated for adolescents only. 3